Monday, March 19, 2012

Provectus Announces Top Line Phase 2 Data For PH-10 in Its First Randomized ... - MarketWatch (press release)

Provectus Announces apical Line Phase 2 collection For PH-10 in Its First Randomized ... MarketWatch (press release) Ninety-nine subjects with mild-to-moderate plaque disease of the skin of the trunk and/or extremities were randomized to one of the iv study arms and practical their assigned test nonfictional prose once daily for xxviii consecutive days. Subjects were assessed weekly during ... and more » Link To Article

No comments:

Post a Comment